2.22

0.56% 0.00

Iovance Biotherapeutics Inc (IOVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IOVA Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.22

Aprire:

$2.26

Volume 24 ore:

8.31M

Relative Volume:

0.57

Capitalizzazione di mercato:

$803.32M

Reddito:

$241.53M

Utile/perdita netta:

$-389.92M

Rapporto P/E:

-1.8049

EPS:

-1.23

Flusso di cassa netto:

$-323.54M

1 W Prestazione:

-7.75%

1M Prestazione:

-10.70%

6M Prestazione:

-37.46%

1 anno Prestazione:

-78.05%

Intervallo 1D:

$2.21

$2.34

Intervallo di 1 settimana:

$2.19

$2.43

Portata 52W:

$1.6385

$12.51

Iovance Biotherapeutics Inc Stock (IOVA) Company Profile

Nome

Iovance Biotherapeutics Inc

Settore

Healthcare (1157)

Industria

Biotechnology (643)

Telefono

(650) 260-7120

Indirizzo

825 INDUSTRIAL ROAD, SAN CARLOS

Dipendente

838

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

IOVA's Discussions on Twitter

Confronta IOVA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IOVA Iovance Biotherapeutics Inc	2.22	803.32M	241.53M	-389.92M	-323.54M	-1.23
VRTX Vertex Pharmaceuticals Inc	386.81	99.26B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	599.10	62.06B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	451.00	59.21B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	737.50	44.94B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	341.56	36.57B	3.81B	-644.79M	-669.77M	-6.24

Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-15	Downgrade	Goldman	Neutral → Sell
2025-05-16	Downgrade	UBS	Buy → Neutral
2025-05-12	Downgrade	Truist	Buy → Hold
2025-05-09	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
2024-10-24	Iniziato	UBS	Buy
2024-07-29	Downgrade	Piper Sandler	Overweight → Neutral
2023-11-20	Iniziato	Goldman	Buy
2023-09-18	Reiterato	Barclays	Overweight
2023-05-30	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-03-27	Ripresa	Wells Fargo	Equal Weight
2023-01-27	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-12-09	Downgrade	Goldman	Buy → Neutral
2022-10-31	Iniziato	Guggenheim	Neutral
2022-08-18	Ripresa	Wells Fargo	Equal Weight
2022-01-28	Aggiornamento	Stifel	Hold → Buy
2021-12-07	Ripresa	Cowen	Outperform
2021-06-10	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2021-05-20	Downgrade	Piper Sandler	Overweight → Neutral
2021-05-19	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2021-05-19	Downgrade	Stifel	Buy → Hold
2021-05-03	Iniziato	Truist	Buy
2021-04-16	Iniziato	Goldman	Buy
2021-03-08	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-12-15	Downgrade	H.C. Wainwright	Buy → Neutral
2020-10-06	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-04-22	Iniziato	Mizuho	Buy
2020-03-04	Iniziato	Barclays	Overweight
2020-02-26	Reiterato	H.C. Wainwright	Buy
2020-02-26	Reiterato	Oppenheimer	Outperform
2019-12-18	Iniziato	JMP Securities	Mkt Outperform
2019-10-01	Iniziato	Stifel	Buy
2019-04-29	Iniziato	Piper Jaffray	Overweight
2019-02-28	Reiterato	Chardan Capital Markets	Buy
2019-02-07	Iniziato	Robert W. Baird	Outperform
2018-12-31	Ripresa	B. Riley FBR	Buy
2018-07-06	Reiterato	Chardan Capital Markets	Buy
2018-04-10	Aggiornamento	B. Riley FBR, Inc.	Neutral → Buy
2018-03-13	Reiterato	B. Riley FBR, Inc.	Neutral
2018-02-23	Downgrade	B. Riley FBR, Inc.	Buy → Neutral
2018-01-25	Reiterato	H.C. Wainwright	Buy
2017-11-01	Reiterato	B. Riley FBR, Inc.	Buy

Mostra tutto

Iovance Biotherapeutics Inc Borsa (IOVA) Ultime notizie

04:22 AM

Earnings Recap: Why is Iovance Biotherapeutics Inc stock going upJuly 2025 Earnings & Real-Time Buy Signal Alerts - خودرو بانک

04:22 AM

Sep 17, 2025

Advancing Cancer Research Brings New Hope for Patients Worldwide - Benzinga

Sep 17, 2025

Bearish Setup: Can Iovance Biotherapeutics Inc stock double in the next yearJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - خودرو بانک

Sep 17, 2025

Sep 16, 2025

Sectors Review: Is Iovance Biotherapeutics Inc attractive at current valuationFed Meeting & Free Long-Term Investment Growth Plans - خودرو بانک

Sep 16, 2025

Aug Chart Watch: Is Iovance Biotherapeutics Inc being accumulated by smart moneyGap Up & Weekly Top Performers Watchlists - خودرو بانک

Sep 16, 2025

Iovance Biotherapeutics Updates Corporate Presentation - MSN

Sep 16, 2025

Aug Breakouts: Is Iovance Biotherapeutics Inc forming a bullish divergenceQuarterly Trade Report & Consistent Profit Trading Strategies - خودرو بانک

Sep 16, 2025

Fibrogen leads drug developer stock gains on China sale, FDA update - BioWorld MedTech

Sep 16, 2025

Is Iovance Biotherapeutics Inc showing insider buyingTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک

Sep 16, 2025

Sep 15, 2025

Nasdaq Moves: How does Iovance Biotherapeutics Inc score in quality rankingsJuly 2025 Highlights & Entry and Exit Point Strategies - خودرو بانک

Sep 15, 2025

Published on: 2025-09-16 06:42:56 - خودرو بانک

Sep 15, 2025

Entry Recap: Should I buy Iovance Biotherapeutics Inc. stock now2025 Technical Patterns & Weekly High Conviction Ideas - خودرو بانک

Sep 15, 2025

Market Overview: Can Iovance Biotherapeutics Inc. maintain sales growth2025 Retail Activity & Stepwise Swing Trade Plans - خودرو بانک

Sep 15, 2025

Stock Analysis: Why is Iovance Biotherapeutics Inc stock going upJuly 2025 Rallies & Capital Protection Trading Alerts - خودرو بانک

Sep 15, 2025

Bull Run: Will Iovance Biotherapeutics Inc benefit from AI trends2025 Geopolitical Influence & Entry and Exit Point Strategies - خودرو بانک

Sep 15, 2025

RSI Check: What are Iovance Biotherapeutics Inc.’s earnings expectationsEarnings Beat & Real-Time Volume Analysis - خودرو بانک

Sep 15, 2025

Iovance falls after missing Q2 expectation - MSN

Sep 15, 2025

Sep 14, 2025

Jacobs Levy Equity Management Inc. Invests $4.19 Million in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat

Sep 14, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Hold" by Brokerages - MarketBeat

Sep 14, 2025

Sep 12, 2025